A Risk Model Developed Based on Homologous Recombination Deficiency Predicts Overall Survival in Patients With Lower Grade Glioma

The role of homologous recombination deficiency (HRD) in lower grade glioma (LGG) has not been elucidated, and accurate prognostic prediction is also important for the treatment and management of LGG. The aim of this study was to construct an HRD-based risk model and to explore the immunological and...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Hao, Wang, Yibiao, Wang, Pengcheng, Huang, Chuixue, Liu, Zhaohui, Wu, Changwu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283922/
https://www.ncbi.nlm.nih.gov/pubmed/35846118
http://dx.doi.org/10.3389/fgene.2022.919391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283922/
https://www.ncbi.nlm.nih.gov/pubmed/35846118
http://dx.doi.org/10.3389/fgene.2022.919391

Ejemplares similares